John D. Norris

6.7k citations

60 papers · 5.0k indexed · h-index 35

Impact in

Genetics top 0.5%
- Estrogen and related hormone effects
Toxicology top 1%

Papers in

Genetics 39
- Estrogen and related hormone effects 36
Toxicology 3

Co-authors: Donald P. McDonnell Ching‐yi Chang Daju Fan Dana M. Fowlkes Lisa A. Paige Paul T. Hamilton Dale J. Christensen Suzanne E. Wardell
Journals: Molecular Endocrinology (6 papers)Cancer Research (5 papers)Journal of Biological Chemistry (3 papers)Endocrinology (3 papers)Clinical Cancer Research (2 papers)
Partner nations: United States Germany Spain

In The Last Decade

John D. Norris

60 papers receiving 4.9k citations

Peers

Countries citing papers authored by John D. Norris

Since Specialization

Citations

This map shows the geographic impact of John D. Norris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Norris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Norris more than expected).

Fields of papers citing papers by John D. Norris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Norris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Norris. The network helps show where John D. Norris may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John D. Norris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John D. Norris Line = papers co-authored together John D. Norris links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide Clinical Cancer Research ·Susan Halabi, E. v. Angerer, Joseph J. Park, David M. Nanus, Daniel J. George, Emmanuel S. Antonarakis, Daniel C. Danila, Russell Z. Szmulewitz, Donald P. McDonnell, John D. Norris, Changxue Lu, Jun Luo, Andrew J. Armstrong	2024	8
2	Structural Determinants of the Binding and Activation of Estrogen Receptor α by Phenolic Thieno[2,3‐ d ]pyrimidines Helvetica Chimica Acta ·Cheng Gong, Brian Anderson, John D. Norris, Chad Torrice, J Y P Leite, Shubin Liu, Barbara Locascio, Konstantin I. Popov, Sean W. Fanning, Donald P. McDonnell, Timothy M. Willson	2023	2
3	A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3- d ]pyrimidine Core ACS Medicinal Chemistry Letters ·Cheng Gong, John D. Norris, Sandeep Artham, Chad Torrice, ライオン史料センター, J Y P Leite, Sean W. Fanning, Donald P. McDonnell, Timothy M. Willson	2022	2
4	The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor Molecular Cancer Therapeutics ·Meliana Cahyaningrum, クリストファー・D エルビッジ, Sunghee Park, Rachid Safi, Sandeep Artham, Steffi Oesterreich, Rinath Jeselsohn, Myles Brown, Sarah Sammons, Suzanne E. Wardell, Ching‐yi Chang, John D. Norris, Donald P. McDonnell	2020	27
5	G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer Breast Cancer Research and Treatment ·Meliana Cahyaningrum, Suzanne E. Wardell, クリストファー・D エルビッジ, 李秉謙李秉謙, Robert Baldi, Christina Chao, Noah Vardi, 林津武, Rui Xiong, Debra A. Tonetti, 周洁颖, Jiong Zhao, Jessica A. Sorrentino, Y Tachimori, John Bisi, Jay C. Strum, Gregory R. J. Thatcher, John D. Norris	2020	37
6	Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy Breast Cancer Research and Treatment ·Suzanne E. Wardell, 香里東, Christina Chao, 林津武, Meliana Cahyaningrum, 李秉謙李秉謙, Noah Vardi, Jeremy T. Blitzer, John D. Norris, Donald P. McDonnell	2019	25
7	CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC Molecular Cancer Research ·James P. Stice, Suzanne E. Wardell, John D. Norris, 香里東, Holly M. Alley, Jean Claude Pector, Chris Meiera, Rachid Safi, Peter Winter, Nurhasanah Hidajati, Rigel J. Kishton, Scott A. Lawrence, Jay C. Strum, Donald P. McDonnell	2017	22
8	MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression Hormones and Cancer ·Jessica L. Christenson, Kiel T. Carson Butterfield, Nicole S. Spoelstra, John D. Norris, J.S. Josan, Julie A. Pollock, Donald P. McDonnell, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Jennifer K. Richer	2017	49
9	Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer Journal of Clinical Investigation ·John D. Norris, Stephanie J. Ellison, クリストファー・D エルビッジ, David B. Stagg, Suzanne E. Wardell, Sung Hee Park, Holly M. Alley, Robert Baldi, 香里東, Meliana Cahyaningrum, James P. Stice, Scott A. Lawrence, Joel R. Eisner, Douglas K. Price, William R. Moore, William D. Figg, Donald P. McDonnell	2017	38
10	Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer Clinical Cancer Research ·Suzanne E. Wardell, Matthew J. Ellis, Holly M. Alley, Zorayda C. Gavino, Todd VanArsdale, Stephen G. Dann, Kim Arndt, Tina Primeau, Elizabeth Griffin, Jieya Shao, Robert G. Crowder, Jinping Lai, John D. Norris, Donald P. McDonnell, Shunqiang Li	2015	115
11	Small‐Molecule‐Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging Angewandte Chemie International Edition ·Jeffrey L. Gustafson, Taavi K. Neklesa, Daniel Alexander Trawin, Anke G. Roth, Dennis L. Buckley, Hyun Seop Tae, Thomas B. Sundberg, David B. Stagg, John Hines, Donald P. McDonnell, John D. Norris, Craig M. Crews	2015	165
12	Bisphenol A affects androgen receptor function via multiple mechanisms Chemico-Biological Interactions ·Christina T. Teng, Bonnie L. Goodwin, Keith R. Shockley, Menghang Xia, Ruili Huang, John D. Norris, B. Alex Merrick, Anton M. Jetten, Christopher P. Austin, Raymond R. Tice	2013	163
13	Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands Chemistry & Biology ·John D. Norris, James D. Joseph, Andrea B. Sherk, Dalia Juzumiene, Philip Turnbull, Nelisiwe Mkize, Huaxia Cui, E. L. Anderson, Daju Fan, Hanady J Mahmmoed, Xiang Deng, Dmitri Kazmin, Ching‐yi Chang, Timothy M. Willson, Donald P. McDonnell	2009	43
14	The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens Molecular Cell ·John D. Norris, Ching‐yi Chang, Bryan M. Wittmann, Rebecca Kunder, Huaxia Cui, Daju Fan, James D. Joseph, Donald P. McDonnell	2009	162
15	Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic Cancer Research ·Andrea B. Sherk, Daniel E. Frigo, Christine G. Schnackenberg, Jeffrey D. Bray, Nicholas J. Laping, Walter Trizna, Marlys Hammond, Jaclyn R. Patterson, Scott K. Thompson, Dmitri Kazmin, John D. Norris, Donald P. McDonnell	2008	174
16	Elucidation of the molecular mechanism of action of selective estrogen receptor modulators The American Journal of Cardiology ·Donald P. McDonnell, Jerome Lincoln Starr, Ching‐yi Chang, John D. Norris	2002	49
17	AMJ volume 25 issue 4 Cover and Front matter American Journal of Law & Medicine ·M. Stemerowicz, Juan Amodia de la Riva, Tadeusz Dzbeński, Joseph F. Brodley, Stephen J. Marx, Kenneth C. Almquist, Christine E. Marx, Philip R. Reilly, L. K. Malafeeva, Sara Rosenbaum, Gianfranco Botta, John D. Lantos, Benjamin Moulton, Barrett Connie, John D. Norris, Michael R. Vasko, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1999	1
18	Enhancement of Estrogen Receptor Transcriptional Activity by the Coactivator GRIP-1 Highlights the Role of Activation Function 2 in Determining Estrogen Receptor Pharmacology Journal of Biological Chemistry ·John D. Norris, Daju Fan, Michael R. Stallcup, Donald P. McDonnell	1998	91
19	Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone Osteoporosis International ·Donald P. McDonnell, John D. Norris	1997	38
20	Structure-Function Relationships of the Complement Regulatory Protein, CD59 Blood Cells Molecules and Diseases ·John G. Petranka, Ji Zhao, John D. Norris, Neil B. Tweedy, Russell E. Ware, Peter J. Sims, Wendell F. Rosse	1996	38

About John D. Norris

John D. Norris is a scholar working on Genetics, Toxicology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 60 papers that have together received 5.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (36 papers), Prostate Cancer Treatment and Research (16 papers), Advanced Breast Cancer Therapies (8 papers), HER2/EGFR in Cancer Research (7 papers), Receptor Mechanisms and Signaling (6 papers), Hormonal and reproductive studies (5 papers), Retinoids in leukemia and cellular processes (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Genetics (2.8k citations), Toxicology (165 citations), Molecular Biology (2.7k citations), Oncology (1.0k citations) and Cancer Research (571 citations). John D. Norris has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Donald P. McDonnell, Ching‐yi Chang, Daju Fan, Dana M. Fowlkes, Lisa A. Paige, Paul T. Hamilton, Dale J. Christensen, Suzanne E. Wardell, Hanne Grøn and Timothy M. Willson. Their work appears in journals such as Molecular Endocrinology, Cancer Research, Journal of Biological Chemistry, Endocrinology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact